Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CRBP

Corbus Pharmaceuticals Holdings Inc

Feb 04 • 04:00PM ET

9.65

Dollar change +0.14
Percentage change 1.47	%

Healthcare • Biotechnology • USA • NASD

Peers: VRTX BMRN GILD NBIX INCY EXEL FOLD NKTR PBYI XOMA

| Held by: VTI IWM VXF VTWO IWO SCHA IWN IWC ITOT GSSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.70	Insider Own	10.55%	Shs Outstand	12.18M	Perf Week	-2.33%
Market Cap	117.53M	Forward P/E	-	EPS next Y	-5.66	Insider Trans	37.43%	Shs Float	10.89M	Perf Month	-19.85%
Income	-38.70M	PEG	-	EPS next Q	-1.24	Inst Own	95.54%	Short Float	22.01%	Perf Quarter	-39.54%
Sales	0.00M	P/S	-	EPS this Y	58.20%	Inst Trans	6.50%	Short Ratio	8.52	Perf Half Y	-82.97%
Book/sh	12.36	P/B	0.78	EPS next Y	-31.32%	ROA	-38.61%	Short Interest	2.40M	Perf Year	-65.28%
Cash/sh	13.11	P/C	0.74	EPS next 5Y	19.03%	ROE	-51.32%	52W Range	9.11 - 61.90	Perf YTD	-18.22%
Dividend Est.	-	P/FCF	-	EPS past 5Y	18.86%	ROI	-25.37%	52W High	-84.41%	Beta	2.59
Dividend TTM	-	Quick Ratio	13.84	Sales past 5Y	-66.68%	Gross Margin	-	52W Low	5.93%	ATR (14)	0.75
Dividend Ex-Date	-	Current Ratio	13.84	EPS Y/Y TTM	58.00%	Oper. Margin	-	RSI (14)	31.19	Volatility	5.45% 6.57%
Employees	19	Debt/Eq	0.02	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	57.00
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	49.52%	Payout	-	Rel Volume	0.60	Prev Close	9.51
Sales Surprise	-	EPS Surprise	-20.81%	Sales Q/Q	-	Earnings	Nov 07 BMO	Avg Volume	281.28K	Price	9.65
SMA20	-13.27%	SMA50	-28.21%	SMA200	-71.35%	Trades		Volume	167,839	Change	1.47%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-24	Initiated	Piper Sandler	Overweight
Jul-30-24	Initiated	Wedbush	Outperform	$85
Jul-22-24	Resumed	H.C. Wainwright	Buy	$80
Jun-26-24	Initiated	B. Riley Securities	Buy	$85
Jun-03-24	Reiterated	Oppenheimer	Outperform	$60 → $80
May-13-24	Initiated	RBC Capital Mkts	Outperform	$77
Mar-06-24	Upgrade	Jefferies	Hold → Buy	$4 → $46
Sep-08-20	Downgrade	ROTH Capital	Buy → Neutral	$40 → $3
Sep-08-20	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Sep-08-20	Downgrade	Jefferies	Buy → Hold	$18 → $2.50
Sep-08-20	Downgrade	BTIG Research	Buy → Neutral
Jul-07-20	Initiated	ROTH Capital	Buy	$40
Jun-17-20	Initiated	BTIG Research	Buy	$22
Mar-26-20	Initiated	Nomura	Buy	$12
Apr-05-19	Initiated	Jefferies	Buy
Mar-20-19	Initiated	Oppenheimer	Outperform	$28
Jan-11-19	Reiterated	Cantor Fitzgerald	Overweight	$36 → $38
Dec-26-18	Initiated	H.C. Wainwright	Buy	$24
Dec-07-18	Initiated	RBC Capital Mkts	Outperform	$23
Oct-24-18	Initiated	B. Riley FBR	Buy	$22

Show Previous Ratings

Jan-28-25 08:00AM	Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference (GlobeNewswire)
Jan-08-25 08:00AM	Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025 (GlobeNewswire)
Jan-06-25 08:00AM	Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-09-24 07:00AM	Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors (GlobeNewswire)
Dec-04-24 12:31PM	Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? (Insider Monkey)
07:00AM	Loading…
Dec-03-24 07:00AM	FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer (GlobeNewswire) -6.11%
Nov-26-24 06:54AM	Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now (Insider Monkey)
Nov-21-24 08:00AM	Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference (GlobeNewswire)
Nov-12-24 08:00AM	Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference (GlobeNewswire)
Nov-07-24 07:28AM	Corbus Pharmaceuticals: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update (GlobeNewswire)
Nov-04-24 04:10PM	Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat (Investor's Business Daily) +8.22%
07:00AM	Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024 (GlobeNewswire)
Oct-29-24 08:00AM	Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference (GlobeNewswire)
Oct-16-24 08:00AM	Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701) (GlobeNewswire)
07:02PM	Loading…
Oct-15-24 07:02PM	Millennium Management LLC Adjusts Stake in Corbus Pharmaceuticals (GuruFocus.com)
Oct-11-24 07:02PM	Octagon Capital Advisors LP Increases Stake in Corbus Pharmaceuticals Holdings Inc (GuruFocus.com)
Oct-03-24 05:07AM	Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) the Best Russell 2000 Stock to Buy According to Analysts? (Insider Monkey)
Sep-26-24 08:00AM	Corbus Pharmaceuticals to Participate in the BMO Capital Markets' Oncology Summit (GlobeNewswire)
Sep-24-24 09:41PM	Cormorant Asset Management's Strategic Acquisition in Corbus Pharmaceuticals (GuruFocus.com) +16.41%
Sep-20-24 03:18PM	Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players (Benzinga) -62.26%
Sep-12-24 07:59AM	Transforming Cancer Therapy Stocks to Watch In The Oncology Sector (News Direct)
Sep-05-24 08:00AM	Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference (GlobeNewswire) -8.32%
Sep-04-24 07:29PM	Corbus Pharmaceuticals Holdings, Inc. (CRBP): This Small-Cap Healthcare Stock Is A Good Buy Right Now (Insider Monkey)
Sep-02-24 05:22PM	10 Best Small-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Aug-27-24 08:03PM	Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimers Top Stock Picks For the Next 12 Months (Insider Monkey)
Aug-26-24 09:55AM	Wall Street Analysts Think Corbus Pharmaceuticals (CRBP) Could Surge 43.82%: Read This Before Placing a Bet (Zacks)
Aug-21-24 05:00AM	The Future of Medicine: Key Biotech Stocks to Watch (News Direct) +7.45%
Aug-20-24 08:00AM	Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung (GlobeNewswire)
Aug-09-24 12:00PM	Corbus Pharmaceuticals (CRBP) Upgraded to Buy: Here's Why (Zacks) +5.54%
09:55AM	Loading…
09:55AM	Wall Street Analysts Believe Corbus Pharmaceuticals (CRBP) Could Rally 54.24%: Here's is How to Trade (Zacks)
Aug-06-24 08:08AM	Corbus Pharmaceuticals: Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update (GlobeNewswire)
Jul-30-24 08:50AM	Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August (GlobeNewswire) +7.13%
Jul-01-24 11:13AM	Google DeepMind CEO: 'This Is the Next $100 Billion AI Business' (InvestorPlace) +9.17%
Jun-30-24 10:13AM	Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn't Discovered Yet (InvestorPlace)
Jun-01-24 10:00AM	SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024 (GlobeNewswire)
May-30-24 08:00AM	Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference (GlobeNewswire)
May-23-24 05:05PM	Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting (GlobeNewswire) -7.96% +8.80%
May-17-24 04:12PM	Google DeepMind CEO: 'This Is the Next $100 Billion AI Business' (InvestorPlace) +7.89%
May-09-24 08:00AM	Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-07-24 01:52PM	CRBP Stock Earnings: Corbus Pharmaceuticals Beats EPS for Q1 2024 (InvestorPlace)
08:17AM	Corbus Pharmaceuticals: Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-06-24 02:06PM	How the Medical Industry Could Produce the Biggest AI Stock Winners (InvestorPlace)
May-01-24 08:00AM	Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum (GlobeNewswire)
Apr-24-24 04:05PM	Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting (GlobeNewswire) -5.83% -5.74%
Apr-19-24 02:30PM	These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher? (InvestorPlace) +7.42%
Apr-16-24 08:50AM	Here's What Could Help Corbus Pharmaceuticals (CRBP) Maintain Its Recent Price Strength (Zacks)
Apr-12-24 06:40AM	7 A-Rated Aggressive Biotech Stocks to Bet On in 2024 (InvestorPlace)
Apr-02-24 08:00AM	Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (GlobeNewswire)
Mar-15-24 08:50AM	What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing' (Zacks)
Mar-14-24 09:38AM	12 Most Profitable Biotech Stocks To Invest In (Insider Monkey)
Mar-12-24 08:21AM	Corbus Pharmaceuticals: Q4 Earnings Snapshot (Associated Press Finance) +16.46%
08:00AM	Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-06-24 08:00AM	Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit (GlobeNewswire)
Feb-28-24 08:00AM	Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer (GlobeNewswire) +7.40%
Feb-06-24 09:50AM	Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Feb-02-24 04:01PM	Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Jan-31-24 09:19AM	Corbus Pharmaceuticals Announces Pricing of Public Offering (GlobeNewswire) +5.29%
Jan-30-24 06:55PM	Corbus Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire) +35.12%
Jan-29-24 06:57AM	Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate (News Direct) -36.86%
Jan-26-24 07:30AM	CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024 (GlobeNewswire) +249.41%
Jan-23-24 08:00AM	Phase 1 Clinical Data for SYS6002 (CRB-701) to be presented at 2024 ASCO GU (GlobeNewswire)
Jan-09-24 08:00AM	Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti- v 8 monoclonal antibody (CRB-601) (GlobeNewswire)
Dec-18-23 08:00AM	Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU (GlobeNewswire)
Dec-01-23 09:40AM	Is Corbus Pharmaceuticals (CRBP) Stock Outpacing Its Medical Peers This Year? (Zacks)
Nov-07-23 09:56AM	Corbus Pharmaceuticals Reports Q3 2023 Financial Results with a Net Loss of $10.1 Million (GuruFocus.com) -16.67%
08:11AM	Corbus Pharmaceuticals: Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-02-23 08:00AM	Corbus Pharmaceuticals Presents Results of Two Pre-Clinical Studies on its Anti- V 8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting (GlobeNewswire)
Oct-17-23 08:00AM	Corbus Pharmaceuticals Announces Publication of Data for its Novel Cannabinoid Type-1 Receptor Inverse Agonist in a Pre-Clinical Model of Obesity Along with Presentations at Obesity Week 2023 (GlobeNewswire)
Oct-16-23 08:00AM	Corbus Pharmaceuticals Presents the First Pre-Clinical Characterization of its Next Generation Nectin-4 ADC CRB-701 (GlobeNewswire)
Oct-03-23 08:00AM	Corbus Pharmaceuticals to Host Virtual 'Meet the Expert' Series (Session 2) on CRB-701 on October 10, 2023 (GlobeNewswire)
Sep-27-23 09:05AM	Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting (PR Newswire)
Sep-19-23 08:00AM	Corbus Pharmaceuticals to Present Pre-Clinical Data Characterizing its CRB-701 Nectin-4 ADC at the at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (PR Newswire)
Aug-08-23 09:08AM	Corbus Pharmaceuticals: Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
Jul-31-23 08:00AM	Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference (PR Newswire) +9.09%
Jul-26-23 05:11PM	26 Biggest Marijuana Companies in the World (Insider Monkey)
Jun-26-23 08:00AM	Corbus Pharmaceuticals Set to Join Russell Microcap® Index (PR Newswire) -7.74%
May-31-23 08:00AM	Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference (PR Newswire) +6.76%
May-30-23 08:45PM	Oppenheimer Sees Over 50% Gains in These 2 Stocks Heres Why They Could Soar (TipRanks) -10.58%
May-09-23 08:11AM	Corbus Pharmaceuticals: Q1 Earnings Snapshot (AP Finance) -12.44%
08:00AM	Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
May-01-23 08:00AM	Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on CRB-601 av8 Blocking Antibody at the New York Academy of Sciences' Frontiers in Cancer Immunotherapy Meeting (PR Newswire)
Apr-18-23 08:00AM	Corbus Pharmaceuticals Hosting Virtual 'Meet the Expert' Series: Blocking TGF with CRB-601--a New Play for an Old Target (PR Newswire) +14.72%
Apr-17-23 08:30AM	Corbus Pharmaceuticals Presents Latest Pre-Clinical Data on CRB-601 at the 2023 American Association for Cancer Research Annual Meeting (PR Newswire) +9.07%
Mar-14-23 04:35PM	Corbus Pharmaceuticals Data on CRB-601 av8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting (PR Newswire) +36.44% -5.21%
Mar-07-23 08:00AM	Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update (PR Newswire) -6.67%
Mar-06-23 08:00AM	Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA (PR Newswire)
Mar-02-23 08:00AM	Corbus Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference (PR Newswire) +5.36%
Feb-13-23 11:27AM	Corbus Pharma Expands Precision Oncology Pipeline With Addition Of Clinical-Stage Antibody Drug Conjugate (Benzinga) -11.06%
06:55AM	Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) (PR Newswire)
Nov-10-22 09:05AM	Corbus Presents Latest Preclinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (PR Newswire)
Nov-08-22 08:05AM	Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
Nov-03-22 05:00PM	15 Best High Volume Penny Stocks to Buy Now (Insider Monkey)
Oct-14-22 08:05AM	Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (PR Newswire) -9.50%
Sep-26-22 08:05AM	Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors (PR Newswire) -6.38%
Sep-22-22 08:00AM	Corbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual Conference (PR Newswire)

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cormorant Asset Management, LP	10% Owner	Sep 20 '24	Buy	20.01	350,000	7,003,761	2,375,000	Sep 24 04:04 PM
CATLIN AVERY W	Director	Sep 04 '24	Proposed Sale	56.43	888	50,109		Sep 04 04:44 PM
Moran Sean F.	Chief Financial Officer	Jun 17 '24	Option Exercise	14.10	6,730	94,893	55,335	Jun 18 05:59 PM
Moran Sean F.	Chief Financial Officer	Jun 14 '24	Option Exercise	8.57	9,355	80,187	56,393	Jun 18 05:59 PM
Moran Sean F.	Chief Financial Officer	Jun 18 '24	Option Exercise	30.00	1,958	58,740	50,563	Jun 18 05:59 PM
Moran Sean F.	Chief Financial Officer	Jun 14 '24	Sale	49.87	9,355	466,569	48,605	Jun 18 05:59 PM
Moran Sean F.	Chief Financial Officer	Jun 17 '24	Sale	46.77	6,730	314,789	48,605	Jun 18 05:59 PM
Moran Sean F.	Chief Financial Officer	Jun 18 '24	Sale	42.12	1,958	82,479	48,605	Jun 18 05:59 PM
Cohen Yuval	Chief Executive Officer	Jun 18 '24	Option Exercise	24.42	15,759	384,859	96,067	Jun 18 05:58 PM
Cohen Yuval	Chief Executive Officer	Jun 14 '24	Option Exercise	9.91	29,317	290,498	101,230	Jun 18 05:58 PM
Cohen Yuval	Chief Executive Officer	Jun 17 '24	Option Exercise	25.90	11,103	287,530	93,733	Jun 18 05:58 PM
Cohen Yuval	Chief Executive Officer	Jun 14 '24	Sale	50.17	29,317	1,470,722	84,400	Jun 18 05:58 PM
Cohen Yuval	Chief Executive Officer	Jun 18 '24	Sale	42.24	22,938	968,832	77,221	Jun 18 05:58 PM
Cohen Yuval	Chief Executive Officer	Jun 17 '24	Sale	46.02	11,103	510,963	84,400	Jun 18 05:58 PM
HOLMER ALAN F	Director	Jun 14 '24	Option Exercise	30.00	1,667	50,010	5,829	Jun 14 04:24 PM
Moran Sean F.	Chief Financial Officer	Apr 10 '24	Option Exercise	30.00	1,787	53,610	48,605	Apr 11 09:17 AM
Cormorant Asset Management, LP	10% Owner	Mar 08 '24	Buy	44.38	300,000	13,314,193	2,025,000	Mar 11 05:34 PM
Cormorant Asset Management, LP	10% Owner	Mar 07 '24	Buy	40.05	250,000	10,013,367	1,725,000	Mar 11 05:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRBP

Corbus Pharmaceuticals Holdings Inc

Upgrade your FINVIZ experience